ID: ALA1830612

Max Phase: Preclinical

Molecular Formula: C36H26F3N5O

Molecular Weight: 601.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1cccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)c1

Standard InChI:  InChI=1S/C36H26F3N5O/c37-36(38,39)34-22-33(27-10-15-32-26(21-27)9-8-25-5-1-2-7-31(25)32)44(41-34)30-13-11-29(12-14-30)42-16-18-43(19-17-42)35(45)28-6-3-4-24(20-28)23-40/h1-15,20-22H,16-19H2

Standard InChI Key:  RVXPXQMRVDSRJN-UHFFFAOYSA-N

Associated Targets(Human)

3-phosphoinositide dependent protein kinase-2, PDK2 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 601.63Molecular Weight (Monoisotopic): 601.2089AlogP: 7.70#Rotatable Bonds: 4
Polar Surface Area: 65.16Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.10CX LogP: 7.76CX LogD: 7.76
Aromatic Rings: 6Heavy Atoms: 45QED Weighted: 0.19Np Likeness Score: -1.36

References

1. Lee SL, Hsu EC, Chou CC, Chuang HC, Bai LY, Kulp SK, Chen CS..  (2011)  Identification and characterization of a novel integrin-linked kinase inhibitor.,  54  (18): [PMID:21823616] [10.1021/jm2007744]

Source